1. Home
  2. VCEL vs AHCO Comparison

VCEL vs AHCO Comparison

Compare VCEL & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$12.93

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
AHCO
Founded
1989
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
VCEL
AHCO
Price
$35.76
$12.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$57.75
$13.50
AVG Volume (30 Days)
557.8K
1.2M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
0.32
N/A
Revenue
$276,259,000.00
$3,244,857,000.00
Revenue This Year
$19.40
$9.00
Revenue Next Year
$18.24
$6.93
P/E Ratio
$106.89
N/A
Revenue Growth
16.45
N/A
52 Week Low
$28.95
$7.91
52 Week High
$45.97
$12.87

Technical Indicators

Market Signals
Indicator
VCEL
AHCO
Relative Strength Index (RSI) 57.65 67.91
Support Level $34.26 $8.72
Resistance Level $38.48 N/A
Average True Range (ATR) 1.31 0.42
MACD 0.18 -0.02
Stochastic Oscillator 94.02 96.80

Price Performance

Historical Comparison
VCEL
AHCO

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

Share on Social Networks: